If you’re on the hunt for stocks to watch today, IDEAYA Biosciences, Inc. (NASDAQ:IDYA) is a stock to give close attention to. The company shares are trading 1.76% or 0.18 points down from last closing price of $10.23, reaching $10.05 at last check. The IDYA share price has dropped in 1 of the last 5 days and is up 43.08% over the past week. It will be exciting to see whether the stock manages to continue decreasing or take a minor break for the next few days. The move came on weak volume too with far less shares changing hands than in a normal session. Trading activity as of this writing weakened by -14,723 shares, and in total 54977 shares valued at $552519 were seen changing hands compared with 69700 shares valued at $713031 recorded at the previous session. You should take into consideration that a falling volume on lower prices shows the bearish trend but this is an early indication which means that the IDYA stock is near its bottom.

IDEAYA Biosciences, Inc. (IDYA) shares have notched a 3-month gain of about 43.08%, but has still advanced 36.4% year to date. By comparison, the stock sank 0% over the past 12 months, while it jumped 32% over the 1 month. The company’s market cap is around $193.45M, with its short interest ratio standing at 1.47%.

In the current trading session for IDYA, the stock witnessed two major price actions, it rose to a high of $11.3 and was down as much as $9.59 at one point. The high recorded is very low when compared to their 52-week high which is $4.89. The 52-week high is now at -41.98 distance from current price. Their recent low of $16.9 represents a 100.51% recovery. This data is quite important for investors who look to benefit from the recent rise of the company’s stock. The price target currently for IDYA is $20.5, this is above the recent high that the stock attained. Taking a look at the overall sentimental views of financial analysts, the trading pattern of this stock recently is very clear.

IDYA‘s last price was up 22.01% as compared to the average trading price of 50 days recorded at $8.24 while enlarging the period to 200 trading days, the average closing price was $7.93. At present, there are 18.91 million in the total number of common shares owned by the public and among those 17.83 million shares have been available to trade. The percentage of shares being held by the company management was 3.7% while institutions stake was 42.2%. The company has generated negative returns on equity over the last 12 months (0%). It managed to keep its gross profit margin at 0% over the past 12 months.

When assessing the full upside of the IDYA stock, there is another set of technicals that should be looked into and considered. Its 14.34% gain from moving average of $8.79 has brought about a positive sentiment when calculated over the last 20 days. The market has allocated a beta of 0 to the stock. With the beta been less than one, this implies that the company shares are theoretically less volatile than the market, something that the traders definitely are keeping an eye on.

Most of the analysts surveyed by Thomson/First Call think quite highly of IDEAYA Biosciences, Inc. — 4 analysts rate the stock as a buy with another 0 rating it strong buy. There are 1 analysts who maintain a hold rating for the stock, with 0 giving it a sell rating. Analysts arrived at a 12-month price target of $19.2 on shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA), which corresponds to 79.78% upside potential than its current market price of $10.05 and implies potential despite the recent drop in the price. However, their current target price has fallen from $19.2 a month ago and is down handily from the consensus target of $19.2 a quarter ago.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.